INmune Bio(INMB) - 2025 Q4 - Earnings Call Transcript

INmune Bio (NasdaqCM:INMB) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsCJ Barnum - Head of NeuroscienceCory Ellspermann - Interim CFODaniel Carlson - Head of Investor RelationsDavid Moss - CEO and Co-FounderElemer Piros - Managing DirectorMark Lowdell - Chief Scientific Officer and Co-FounderOperatorGreetings, and welcome to the INmune Bio's 2025 fourth quarter and year-end earnings call. As a reminder, this conference is being recorded. A transcript will follow within 24 hours of t ...